rs186364861

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_018283.4(NUDT15):​c.52G>A​(p.Val18Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00037 in 1,593,114 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,drug response (no stars).

Frequency

Genomes: 𝑓 0.00041 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 4 hom. )

Consequence

NUDT15
NM_018283.4 missense

Scores

1
8
9

Clinical Significance

Likely benign; drug response no assertion criteria provided B:1O:1

Conservation

PhyloP100: 8.38

Publications

73 publications found
Variant links:
Genes affected
NUDT15 (HGNC:23063): (nudix hydrolase 15) This gene encodes an enzyme that belongs to the Nudix hydrolase superfamily. Members of this superfamily catalyze the hydrolysis of nucleoside diphosphates, including substrates like 8-oxo-dGTP, which are a result of oxidative damage, and can induce base mispairing during DNA replication, causing transversions. The encoded enzyme is a negative regulator of thiopurine activation and toxicity. Mutations in this gene result in poor metabolism of thiopurines, and are associated with thiopurine-induced early leukopenia. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Apr 2016]
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
SUCLA2 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
    Inheritance: Mitochondrial, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009341568).
BP6
Variant 13-48037798-G-A is Benign according to our data. Variant chr13-48037798-G-A is described in ClinVar as [Likely_benign, drug_response]. Clinvar id is 225203.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 62 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUDT15NM_018283.4 linkc.52G>A p.Val18Ile missense_variant Exon 1 of 3 ENST00000258662.3 NP_060753.1 Q9NV35

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUDT15ENST00000258662.3 linkc.52G>A p.Val18Ile missense_variant Exon 1 of 3 1 NM_018283.4 ENSP00000258662.1 Q9NV35
SUCLA2ENST00000646804.1 linkc.-277C>T 5_prime_UTR_variant Exon 1 of 11 ENSP00000493977.1 A0A2R8YDQ9
SUCLA2ENST00000643246.1 linkc.-355C>T 5_prime_UTR_variant Exon 1 of 3 ENSP00000496235.1 A0A2R8YF84

Frequencies

GnomAD3 genomes
AF:
0.000420
AC:
64
AN:
152236
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0112
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000912
AC:
193
AN:
211708
AF XY:
0.000886
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000108
Gnomad EAS exome
AF:
0.0112
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000107
Gnomad OTH exome
AF:
0.000374
GnomAD4 exome
AF:
0.000366
AC:
527
AN:
1440760
Hom.:
4
Cov.:
31
AF XY:
0.000375
AC XY:
268
AN XY:
714488
show subpopulations
African (AFR)
AF:
0.0000600
AC:
2
AN:
33356
American (AMR)
AF:
0.00
AC:
0
AN:
40036
Ashkenazi Jewish (ASJ)
AF:
0.000235
AC:
6
AN:
25578
East Asian (EAS)
AF:
0.0111
AC:
431
AN:
39000
South Asian (SAS)
AF:
0.000351
AC:
29
AN:
82712
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52018
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4492
European-Non Finnish (NFE)
AF:
0.0000127
AC:
14
AN:
1103910
Other (OTH)
AF:
0.000754
AC:
45
AN:
59658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000407
AC:
62
AN:
152354
Hom.:
1
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41590
American (AMR)
AF:
0.00
AC:
0
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.0108
AC:
56
AN:
5164
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000452
Hom.:
0
Bravo
AF:
0.000589
ExAC
AF:
0.000840
AC:
101
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Likely benign; drug response
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

NUDT15-related disorder Benign:1
Mar 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Thiopurines, poor metabolism of, 2 Other:1
Oct 25, 2016
OMIM
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0059
T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
8.4
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.85
N
REVEL
Benign
0.27
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.052
T
Polyphen
1.0
D
Vest4
0.42
MVP
0.21
MPC
0.38
ClinPred
0.12
T
GERP RS
5.6
PromoterAI
-0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.40
gMVP
0.44
Mutation Taster
=268/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186364861; hg19: chr13-48611934; API